Lantern Pharma Inc. LTRN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 06/11/21 EDT
15.58quote price arrow down-0.40 (-2.50%)
Volume
22,797
52 week range
10.40 - 24.84

...

Loading . . .
  • Open15.99
  • Day High16.00
  • Day Low15.57
  • Prev Close15.98
  • 52 Week High24.84
  • 52 Week High Date10/12/20
  • 52 Week Low10.40
  • 52 Week Low Date08/14/20

Key Stats

  • Market Cap174.18M
  • Shares Out11.18M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-16.99

KEY STATS

  • Open15.99
  • Day High16.00
  • Day Low15.57
  • Prev Close15.98
  • 52 Week High24.84
  • 52 Week High Date10/12/20
  • 52 Week Low10.40
  • 52 Week Low Date08/14/20
  • Market Cap174.18M
  • Shares Out11.18M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-16.99

RATIOS/PROFITABILITY

  • EPS (TTM)-1.12
  • P/E (TTM)-13.96
  • Fwd P/E (NTM)-18.61
  • EBITDA (MRQ)-7.879M
  • ROE (MRQ)-19.16%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.13%

EVENTS

  • Earnings Date07/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lantern Pharma Inc.

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Lantern Pharma Inc. is a clinical stage biotechnology company. The Company is focused on developing oncology therapies. It uses its artificial intelligence (AI) platform, RADR, which includes data points, and uses big data analytics to uncover biologically relevant genomic signatures correlated to drug response, and then identify the cancer patients that benefits from its compounds. Its portfolio consists of three compounds: LP-100, LP-300 and LP-184. The Company is...
Donald Keyser J.D., Ph.D.
Chairman
Panna Sharma
President
David Margrave J.D.
Chief Financial Officer
Address
1920 MCKINNEY AVENUE, 7TH FLOOR
Dallas, TX
75201
United States